Psychedelics and Mental Health: A New Path to Healing with Dr. Dana Lerman, Founder & Medical Director at Skylight Psychedelics

Psychedelics are transforming mental health care accessibility and treatment. In this episode, Dr. Dana Lerman shares her journey from being an infectious disease consultant to founding Skylight Psychedelics after facing personal mental health struggles during the COVID pandemic. She discusses her transformative experiences with psychedelic-assisted therapy, including an ayahuasca retreat, and how these therapies catalyzed profound personal changes and a career shift. Dr. Lerman highlights the critical role of psychedelics in enhancing mental health care accessibility, illustrated by her work with insurance companies to provide ketamine-assisted therapy benefits. She emphasizes the potential of psychedelics, like ketamine, in treating conditions such as suicidality, advocating for the de-stigmatization and respectful use of these medicines. Tune in to learn how innovative approaches in psychedelic therapy are reshaping the landscape of mental health care! Resources: Connect with and follow Dana Lerman on LinkedIn. Follow Skylight Psychedelics on LinkedIn and explore their website. Thanks for tuning into the expanding access podcast. Ready to take your knowledge, network, and experience to the next level? Then join us at the BHT Conference in San Diego on November 11-13. Join thought leaders, practitioners, policymakers, and payers focused on expanding access and improving outcomes in mental health, behavioral health, substance abuse, and IDD. Save $100 on your registration here by using your podcast promo code “Podcast100”